Researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial. The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New medications are needed to build up secondary defenses against drug-resistant strains of the parasite.